Oxford Science Enterprises is an independent investment company that finds, funds, and builds transformational science and technology companies emerging from Oxford research.
The funding round will support the company transition to a technology licensing model and expand research capabilities.
"This investment accelerates our ability to develop scalable solutions for our technology partners, helping them navigate the changing global energy landscape. With Barclays’ support, we can bring our technology into more homes and buildings in the UK through a broader range of channels while improving the grid’s capacity to integrate renewable energy. Why pay windfarms to shut down when we can pay households to switch on?"
Cedars-Sinai and Oxford Science Enterprises backed the seed round to support expansion into the American market.
"The research produced at Oxford is of the highest caliber. An ongoing relationship with OSE will serve our patients and also strengthen the academic and clinical missions of Cedars-Sinai."
— Shlomo Melmed, executive vice president of Medicine & Health Sciences and dean of the Medical Faculty
The oversubscribed round was led by BGF and Green Generation Fund to support team growth and facility expansion.
"We are delighted to welcome BGF and Green Generation Fund along with Volta Energy Technologies to our investor base. Their experience of building successful break-through technology businesses in battery and sustainable technologies will be invaluable. With an outstanding investor syndicate to support us, we continue our mission to make fluorochemicals production safer, cheaper, and more sustainable. This investment will play a huge part in our journey to scale and commercialise our proprietary technology with key partners across the global fluorochemical supply chain, and in accelerating the development of a technology that can provide a reliable and localised supply of a key component of Li-ion batteries."
The seed round was co-led by Kindred Capital, NATO Innovation Fund, and Oxford Science Enterprises.
"In today’s AI race, the limitations of existing hardware – nearly all of which is provided by a single company – represent the biggest barrier to better performance, reduced cost, and wider adoption. Fractile’s approach supercharges inference, delivering astonishing improvements in terms of speed and cost. This is more than just a speed-up – changing the performance point for inference allows us to explore completely new ways to use today’s leading AI models to solve the world’s most complex problems. We’re thrilled to have raised our funding from investors with a wealth of experience in the AI and chip industries, continue to grow our world-class team and further our technological development and partnerships."
The oversubscribed round saw backing from investors including André Hoffmann and Oxford Science Enterprises to expand environmental reporting tools.
"It has been truly exciting to see the level of investor interest in our company, particularly in a less-than-optimal fundraising environment globally,"
